This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated NOX1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-NOX1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~64.9 kDa | |
| Observed band | ~65 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Glycosylation affects apparent size | |
| Regulation | IFN-γ-suppressed | |
| Isoform | 2 isoform(s) |
Literature-validated Western blot parameters for NOX1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | rat brain , Lane 2: mouse brain . After electrophoresis, proteins were transferred to a nitrocellulose membrane at 150 mA for 50-90 minutes. Blocked the membrane with 5% non-fat milk/TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-NOX1 antigen affinity purified polyclonal antibody (Catalog # PA1666) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:5000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for NOX1 at approximately 65 kDa. The expected band size for NOX1 is at 65 kDa |
| Gel % | 10–12% |
| Load | 30 ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:5000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 65 kDa |
NOX1 has a 64.9 kDa predicted backbone and runs at almost the same ~65 kDa observed on blots, since its two N-glycosylation sites add only minimal mass.
| Major band at approximately 65 kDa | closely matches the 64.9 kDa predicted mass of the NOX1 core polypeptide, indicating little net mass is added by modification |
| Band appears slightly diffuse or broadened around 65 kDa rather than perfectly sharp | the two N-linked glycosylation sites (Asn162, Asn236) introduce mild glycoform heterogeneity |
| Band sitting just above the 64.9 kDa unmodified backbone mass | carbohydrate added at the Asn162 and Asn236 glycosylation sites accounts for the small upward shift toward the ~65 kDa observed size |
| A second, distinct band at a different apparent molecular weight | co-expression of the NOH-1L and NOH-1LV splice isoforms, which differ in length and migrate differently |
| Only a single isoform-sized band present | one splice variant, NOH-1L or NOH-1LV, predominates in that particular tissue or cell type |
| Predicted core mass (64.9 kDa) | sets the baseline backbone size, closely matching the empirical ~65 kDa band seen on blots |
| N-glycosylation at Asn162 | adds modest carbohydrate mass, nudging the apparent size slightly above the unmodified 64.9 kDa backbone |
| N-glycosylation at Asn236 | contributes additional glycan mass and can cause mild smearing or heterogeneity in the band |
| Splice isoforms NOH-1L and NOH-1LV | differ in length and can appear as separate bands or shift which band predominates depending on tissue |
| Non-glycosylated bacterial recombinant standard | runs at or below the 64.9 kDa predicted mass since it lacks the native N-glycans present on mammalian-expressed NOX1 |
| Situation | Likely cause | Next action |
|---|---|---|
| Band higher than expected | incomplete denaturation or aggregation of the multi-pass transmembrane NOX1 protein | use fresh reducing agent and adequate SDS/detergent, and avoid prolonged boiling which promotes hydrophobic aggregation of membrane proteins |
| Broad smear instead of sharp band | heterogeneous N-glycosylation at Asn162 and Asn236 producing multiple glycoforms | treat lysate with PNGase F to deglycosylate and resolve to a single sharp band near 65 kDa, and run a higher-percentage or gradient gel |
| Multiple bands | co-detection of the NOH-1L and NOH-1LV splice isoforms | confirm isoform identity with an isoform-specific antibody or transcript-level assay and note which isoform predominates in the sample |
| Weak or no signal | NOX1 has restricted, tissue-specific expression with low abundance in many common cell lines | include a known-positive tissue lysate as a control, increase total protein loaded, and extend chemiluminescent exposure |
| No band in lysate | NOX1 is a multi-pass integral membrane protein at the plasma and invadopodium membrane, so standard lysis may not solubilize it efficiently | use a detergent-rich, membrane-protein-compatible lysis buffer and avoid centrifugation steps that discard membrane fractions |
| Band lower than expected | use of a bacterially expressed, non-glycosylated recombinant NOX1 standard lacking native N-glycans | benchmark against native tissue lysate or mammalian-expressed protein rather than bacterial recombinant standards |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for NOX1, answered from its protein features.
BosterBio's NOX1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Boster's anti-NOX1 antibodies (PA1666, PA1739) each come with documented western blot data, giving researchers image-validated, ready-to-use options for detecting NOX1 protein expression in western blot experiments.
Which to pick: Both PA1666 and PA1739 have real WB validation images on file. PA1739 is shown detecting a ~65kD band in HeLa and MCF-7 whole-cell lysates; PA1666 was validated on a 5-20% gradient gel. Pick based on which cell type and predicted band size matches your sample.